@AlexWalker 1 week ago
Is Bristol Myers Squibb Getting Interesting?
Is Bristol Myers Squibb Getting Interesting?
is now trading at a much lower valuation, which has definitely caught my attention. The bigger question for me is whether its pipeline and new drug launches can offset the pressure from key patent expirations. Would you consider at these levels?
@ProduceCut309 1 week ago
The lower valuation is interesting, but patent expirations add a real layer of uncertainty. The pipeline will be key.
